UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

American Society of Clinical Oncology Statement: Biosimilars in Oncology

Journal of clinical oncology, 2018-04, Vol.36 (12), p.1260-1265

2018

Volltextzugriff (PDF)

Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications

Analytica chimica acta, 2019-12, Vol.1089, p.1-18

2019

Volltextzugriff (PDF)

High Resolution CZE-MS Quantitative Characterization of Intact Biopharmaceutical Proteins: Proteoforms of Interferon-β1

Analytical chemistry (Washington), 2016-01, Vol.88 (2), p.1138-1146

2016

Volltextzugriff (PDF)

Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis

Analytical chemistry (Washington), 2017-02, Vol.89 (3), p.2086-2092

2017

Volltextzugriff (PDF)

Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

Nature reviews. Drug discovery, 2012-07, Vol.11 (7), p.527-540

2012

Volltextzugriff (PDF)

Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar

mAbs, 2017-05, Vol.9 (4), p.704-714

2017

Volltextzugriff (PDF)

Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars

Nature biotechnology, 2016-02, Vol.34 (2), p.139-141

2016

Volltextzugriff (PDF)

Biosimilars for Retinal Diseases: An Update

American journal of ophthalmology, 2021-04, Vol.224, p.36-42

2021

Volltextzugriff (PDF)

Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product

mAbs, 2018-04, Vol.10 (3), p.380-396

2018

Volltextzugriff (PDF)

Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry

The AAPS journal, 2015-03, Vol.17 (2), p.339-351

2015

Volltextzugriff (PDF)

Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab

Analytical chemistry (Washington), 2020-02, Vol.92 (4), p.3161-3170

2020

Volltextzugriff (PDF)

Qualification of a LC-HRMS platform method for biosimilar development using NISTmab as a model

Analytical biochemistry, 2024-05, Vol.688, p.115475-115475, Article 115475

2024

Volltextzugriff (PDF)

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)

mAbs, 2017-02, Vol.9 (2), p.364-383

2017

Volltextzugriff (PDF)

In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate

mAbs, 2016-10, Vol.8 (7), p.1210-1223

2016

Volltextzugriff (PDF)

Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies

Journal of mass spectrometry., 2015-02, Vol.50 (2), p.285-297

2015

Volltextzugriff (PDF)

Maintaining consistent quality and clinical performance of biopharmaceuticals

Expert opinion on biological therapy, 2018-04, Vol.18 (4), p.369-379

2018

Volltextzugriff (PDF)

A novel microchip‐based imaged CIEF‐MS system for comprehensive characterization and identification of biopharmaceutical charge variants

Electrophoresis, 2019-12, Vol.40 (23-24), p.3084-3091

2019

Volltextzugriff (PDF)

Low-Flow Sheathless Capillary Electrophoresis–Mass Spectrometry for Sensitive Glycoform Profiling of Intact Pharmaceutical Proteins

Analytical chemistry (Washington), 2013-02, Vol.85 (4), p.2289-2296

2013

Volltextzugriff (PDF)

The similarity question for biologicals and non-biological complex drugs

European journal of pharmaceutical sciences, 2015-08, Vol.76, p.10-17

2015

Volltextzugriff (PDF)

Physicochemical characterization of Remsima

mAbs, 2014-09, Vol.6 (5), p.1163-1177

2014

Volltextzugriff (PDF)

Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab

mAbs, 2018-05, Vol.10 (4), p.678-691

2018

Volltextzugriff (PDF)

Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques

mAbs, 2013-09, Vol.5 (5), p.699-710

2013

Volltextzugriff (PDF)

Physicochemical and Functional Characterization of HS016, a Biosimilar of Adalimumab (Humira)

Journal of pharmaceutical sciences, 2022-04, Vol.111 (4), p.1142-1151

2022

Volltextzugriff (PDF)

Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016-10, Vol.1032, p.61-78

2016

Volltextzugriff (PDF)

Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow

Journal of the American Society for Mass Spectrometry, 2021-08, Vol.32 (8), p.1998-2012

2021

Volltextzugriff (PDF)

1 – 25 von 493

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(464)
Mit Volltextzugriff
(383)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(453)
Life Sciences & Biomedicine
(424)
Humans
(347)
Pharmacology & Pharmacy
(211)
Biosimilar Pharmaceuticals - Chemistry
(202)
Biosimilar
(156)
Chemistry
(153)
Physical Sciences
(147)
Biochemistry & Molecular Biology
(132)
Biological Products
(127)
Animals
(105)
Monoclonal Antibodies
(104)
Biochemical Research Methods
(93)
Biosimilars
(93)
Chemistry, Analytical
(90)
Biosimilar Pharmaceuticals
(87)
Biosimilar Pharmaceuticals - Therapeutic Use
(87)
Biomedicine
(74)
Biomedical And Life Sciences
(72)
Chemistry, Medicinal
(68)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

American Society of Clinical Oncology Statement: Biosimilars in Oncology

Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications

High Resolution CZE-MS Quantitative Characterization of Intact Biopharmaceutical Proteins: Proteoforms of Interferon-β1

Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis

Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar

Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars

Biosimilars for Retinal Diseases: An Update

Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product

Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry

Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab

Qualification of a LC-HRMS platform method for biosimilar development using NISTmab as a model

Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)

In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate

Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies

Maintaining consistent quality and clinical performance of biopharmaceuticals

A novel microchip‐based imaged CIEF‐MS system for comprehensive characterization and identification of biopharmaceutical charge variants

Low-Flow Sheathless Capillary Electrophoresis–Mass Spectrometry for Sensitive Glycoform Profiling of Intact Pharmaceutical Proteins

The similarity question for biologicals and non-biological complex drugs

Physicochemical characterization of Remsima

Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab

Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques

Physicochemical and Functional Characterization of HS016, a Biosimilar of Adalimumab (Humira)

Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products

Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow

Suchergebnisse filtern